Page last updated: 2024-09-04

enkephalin, pen(2,5)-4-chloro-phe(4)- and oxytocin

enkephalin, pen(2,5)-4-chloro-phe(4)- has been researched along with oxytocin in 1 studies

Compound Research Comparison

Studies
(enkephalin, pen(2,5)-4-chloro-phe(4)-)
Trials
(enkephalin, pen(2,5)-4-chloro-phe(4)-)
Recent Studies (post-2010)
(enkephalin, pen(2,5)-4-chloro-phe(4)-)
Studies
(oxytocin)
Trials
(oxytocin)
Recent Studies (post-2010) (oxytocin)
120121,6111,8315,773

Protein Interaction Comparison

ProteinTaxonomyenkephalin, pen(2,5)-4-chloro-phe(4)- (IC50)oxytocin (IC50)
Oxytocin receptorHomo sapiens (human)0.0027

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amico, JA; Brown, DC; Perkowski, SZ; Shofer, F1

Other Studies

1 other study(ies) available for enkephalin, pen(2,5)-4-chloro-phe(4)- and oxytocin

ArticleYear
Effect of centrally administered opioid receptor agonists on CSF and plasma oxytocin concentrations in dogs.
    American journal of veterinary research, 2001, Volume: 62, Issue:4

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Cross-Over Studies; Dogs; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Injections, Spinal; Male; Morphine; Oxytocin; Random Allocation; Receptors, Opioid

2001